(Press-News.org) TORONTO, Oct. 1, 2014 – Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with Type 1 diabetes, according to new research published in the BMJ.
Researchers looked at once-daily and twice-daily doses of both long- and intermediate-acting insulin, ranking their effectiveness, safety and cost-effectiveness.
"In patients with Type 1 diabetes, we found that long-acting insulin is superior to intermediate-acting insulin when it came to controlling blood sugar, preventing weight gain and treating severe hypoglycemia," said Dr. Andrea Tricco, the lead author of the paper and a scientist in the Li Ka Shing Knowledge Institute of St. Michael's Hospital.
Using data from 39 studies, Dr. Tricco and her colleagues compared two long-acting forms of insulin – glargine and detemir – against intermediate-acting forms, such as such as Neutral Protamine Hagedorn.
Long-acting insulin takes about one hour after ingesting to begin lowering blood sugar and lasts up to 26 hours. Intermediate-acting insulin takes between one and three hours to begin lowering blood sugar and can last up to 16 hours.
Compared to intermediate-acting NPH, long-acting insulin significantly improved Hemoglobin A1C levels, a measure of effective blood sugar control over time.
"Those taking intermediate-acting insulin were more likely to gain weight," said Dr. Tricco, who has a PhD in population health and is also an assistant professor in the University of Toronto's Dalla Lana School of Public Health. "They gained an average of four to six pounds more than the participants who took most long-acting insulin doses."
Severe hypoglycemia, when someone has extremely low blood sugar, is a medical emergency where the individual is unable to treat themselves. When someone is severely hypoglycemic, they need someone else to provide them with sugar quickly through food or via intravenous fluids.
The researchers found that people with Type 1 diabetes were 38 per cent less likely to experience severe hypoglycemia, on average.
Dr. Tricco also looked at the cost-effectiveness between the two types of insulin.
Of the 32 studies included in the review, there were 22 analyses evaluating the economic benefits of long- and intermediate-acting insulin. Seventy-seven per cent of those economic analyses found that long-acting insulin was more expensive but also more effective than intermediate-acting insulin. Twenty-three per cent found long-acting insulin more cost-effective.
"With this information, patients and their doctors should tailor their choice of insulin according to preference, cost and accessibility," said Dr. Tricco.
INFORMATION:
This research was funded by the Drug Safety and Effectiveness Network of Canadian Institutes of Health Research.
About St. Michael's Hospital
St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in 27 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.
Media contacts
For more information, or to arrange an interview, please contact:
Geoff Koehler
Adviser, Media Relations
St. Michael's Hospital
416-864-6060 ext. 6537
koehlerg@smh.ca
Long-acting insulin is safer, more effective for patients with Type 1 diabetes
2014-10-01
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
All directions are not created equal for nanoscale heat sources
2014-10-01
Thermal considerations are rapidly becoming one of the most serious design constraints in microelectronics, especially on submicron scale lengths. A study by researchers from the University of Illinois at Urbana-Champaign has shown that standard thermal models will lead to the wrong answer in a three-dimensional heat-transfer problem if the dimensions of the heating element are on the order of one micron or smaller.
"As materials shrink, the rules governing heat transfer change as well," explained David Cahill, a professor of materials science and engineering at Illinois. ...
Microbes in Central Park soil: If they can make it there, they can make it anywhere
2014-10-01
Soil microbes that thrive in the deserts, rainforests, prairies and forests of the world can also be found living beneath New York City's Central Park, according to a surprising new study led by Colorado State University and the University of Colorado Boulder.
The research team analyzed 596 soil samples collected from across Central Park's 843 acres and discovered a stunning diversity of below-ground life, most of which had never been documented before.
Only 8.5 percent to 16.2 percent of the organisms discovered in the park soils, depending on their type, had been ...
Non-citizens face harsher sentencing than citizens in US criminal courts
2014-10-01
WASHINGTON, DC, September 29, 2014 — Non-Americans in the U.S. federal court system are more likely to be sentenced to prison and for longer terms compared to U.S. citizens, according to a new study.
"Much of the discussion in this area has centered around deportation, but increasing numbers of immigrants are being brought before criminal courts, and little is known about how they are treated once they are in the criminal justice system," said Michael T. Light, an assistant professor of sociology at Purdue University and the lead author of the study. "This is a major ...
Immunotherapy could stop resistance to radiotherapy
2014-10-01
Treating cancers with immunotherapy and radiotherapy at the same time could stop them from becoming resistant to treatment, according to a study published in Cancer Research* today (Wednesday).
The researchers, based at The University of Manchester and funded by MedImmune, the global biologics research and development arm of AstraZeneca, and Cancer Research UK, found that combining the two treatments helped the immune system hunt down and destroy cancer cells that weren't killed by the initial radiotherapy in mice with breast, skin and bowel cancers.
Radiotherapy ...
Is Australia prepared for Ebola?
2014-10-01
Australia needs to be proactive about potential disease outbreaks like Ebola and establish a national centre for disease control.
In an Editorial in the October issue of Australian and New Zealand Journal of Public Health, Allen Cheng from Monash University and Heath Kelly from the Australian National University question Australia's preparation for public health crises.
"Australia would do well to heed the lessons learned in other countries and be proactive in co-ordinating a consistent and outward looking response," the authors said.
"Australia needs a national disease ...
Targeted treatment could halt womb cancer growth
2014-10-01
A drug which targets a key gene fault could halt an aggressive womb cancer and shrink tumours, according to research published in the British Journal of Cancer*.
The scientists, from the Division of Gynaecologic Oncology at Yale School of Medicine funded by the National Institutes of Health, showed that the drug afatinib not only killed off uterine serous cancer cells after stopping their growth but also caused tumours to shrink.
The drug, a type of personalised medicine, attacks faults in the HER2 gene which lie at the heart of the cancer cells. This stops the disease ...
Third of countries struggling to meet the needs of aging population
2014-10-01
People around the world are living longer, but social policies to support their wellbeing in later life are lagging behind in many countries. This is according a new report by HelpAge International, developed in partnership with the University of Southampton.
More than a third of countries are falling significantly behind those at the top of the Global AgeWatch Index. It ranks 96 nations on the basis of the quality of life and social and economic wellbeing of older people (over 60s). The Index can also help governments to identify policies and institutional contexts that ...
Developing countries should enroll medical and nursing students from rural areas
2014-10-01
Nearly one third of medical and nursing students in developing countries may have no intention of working in their own countries after graduation, while less than one fifth of them intend to work in rural areas where they are needed most, according to a new study.
Health workforce shortages have been a major factor driving the current outbreak of Ebola in western Africa. The disease initially spread rapidly in rural parts of three of the world's poorest countries (Guinea, Sierra Leone and Liberia), where health workers are scarcest.
The study, which was published in ...
Minimum alcohol pricing would be up to 50 times more effective than below cost selling ban
2014-10-01
The previous policy of setting a minimum unit price would have had a 40-50 times greater effect, particularly among harmful drinkers, say researchers.
Increasing the price of alcohol has been shown to be effective in reducing both consumption levels and harms, and the UK government has been considering different policy options for price regulation in England and Wales.
In 2010, the government announced a ban on "below cost selling" to target drinks which are currently sold so cheaply that their price is below the cost of the tax (duty and VAT) payable on the product. ...
Healthy lifestyle could prevent nearly half of all diabetic pregnancies
2014-10-01
Gestational diabetes is a common pregnancy complication that has long-term adverse health implications for both mothers and babies.
Several modifiable risk factors before pregnancy have been identified over the past decade. These include maintaining a healthy weight, consuming a healthy diet, regular physical activity, and not smoking.
So a team of researchers based in the United States set out to examine the effect of these "low risk" lifestyle factors on the risk of gestational diabetes – and measure the portion of the condition that may be preventable through adhering ...